Table of Content

Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary

Chapter 2 Market Overview
Overview of Gene Synthesis
Gene Synthesis Methods
Gene Synthesis Applications
Scientific Advances in Gene Synthesis
Technological Innovation in Gene Synthesis
Ethical Considerations in Gene Synthesis
Societal Implications

Chapter 3 Market Dynamics
Overview
Market Drivers
Biopharmaceutical R&D
Diagnostic and Therapeutic Applications
Advances in Agrobiotechnology
DNA Data Storage and Synthetic Genomics
Advances and Cost Reductions in Technology
Rising Investments in R&D
Opportunities in Personalized Medicine
Restraints
Cost Constraints
Lack of Quality Control and Standardization
Opportunities
Personalized Medicine and Precision Healthcare
AI in Gene Synthesis
Challenges
Intellectual Property Issues
Long Turnaround Times

Chapter 4 Regulatory Landscape
Biosecurity and Dual-use Concerns
Export Controls and Trade Regulations
Intellectual Property Rights
Regulatory Oversight of Clinical Applications
Ethical and Societal Considerations
Quality Assurance and Product Standards
Regulatory Challenges by Country
United States
Canada
Europe
Japan
India
Brazil

Chapter 5 Emerging Technologies and Developments
Enzymatic DNA Synthesis
Microfluidic DNA Synthesis
Machine Learning and AI
Thermodynamically Balanced Inside-out
Ligase-based Gene Synthesis
Polymerase-based Gene Synthesis
Patent Analysis

Chapter 6 Market Segmentation Analysis
Segmentation Breakdown
Gene Synthesis: Global Market
Global Market for Gene Synthesis, by Method
Solid-phase Synthesis
PCR-based Enzyme Synthesis
Chip-based Synthesis
Global Market for Gene Synthesis, by Services
Antibody DNA Synthesis
Viral DNA Synthesis
Other Gene Synthesis Services
Gene Synthesis: Global Markets, by Application
Gene and Cell Therapy Development
Vaccine Development
Disease Diagnosis
Other Applications
Global Market for Gene Synthesis, by End User
Academic and Government Research Institutes
Biotechnology and Pharmaceutical Companies
Contract Research Organizations
Geographic Breakdown
In-house or Outsource?
Cost Considerations
Quality Control and Assurance
Convenience and Turnaround Time
Customization and Specialization
Strategic Considerations

Chapter 7 Competitive Landscape
Company Rankings
M&A and Venture Funding
In Summation

Chapter 8 Appendix
Methodology
Sources
Abbreviations
Company Profiles
AZENTA US INC.
DANAHER CORP.
EUROFINS SCIENTIFIC
GENSCRIPT
MERCK KGAA
ORIGENE TECHNOLOGIES INC.
PROMAB BIOTECHNOLOGIES INC.
PROTEOGENIX
THERMO FISHER SCIENTIFIC INC.
TWIST BIOSCIENCE



List of Figures


Summary Figure : Global Market for Gene Synthesis, by Services, 2020-2028
Figure 1 : Market Dynamics of Gene Synthesis
Figure 2 : Global Market Shares for Gene Synthesis, by Method, 2022
Figure 3 : Global Market Shares for Gene Synthesis, by Services, 2022
Figure 4 : Global Market Shares for Gene Synthesis, by Application, 2022
Figure 5 : Global Market Shares for Gene Synthesis, by End User, 2022
Figure 6 : Azenta US Inc.: Revenue Shares, by Business Unit, FY 2023
Figure 7 : Azenta US Inc.: Revenue Shares, by Country/Region, FY 2023
Figure 8 : Danaher Corp.: Revenue Shares, by Business Unit, FY 2023
Figure 9 : Danaher Corp.: Revenue Shares, by Country/Region, FY 2023
Figure 10 : Eurofins Scientific: Revenue Shares, by Business Unit, FY 2023
Figure 11 : Eurofins Scientific: Revenue Shares, by Country/Region, FY 2023
Figure 12 : GenScript: Revenue Shares, by Business Unit, FY 2022
Figure 13 : GenScript: Revenue Shares, by Country/Region, FY 2022
Figure 14 : Merck KgaA: Revenue Shares, by Business Unit, FY 2023
Figure 15 : Merck KgaA: Revenue Shares, by Country/Region, FY 2023
Figure 16 : Thermo Fisher Scientific Inc.: Revenue Shares, by Business Unit, FY 2023
Figure 17 : Thermo Fisher Scientific Inc.: Revenue Shares, by Country/Region, FY 2023
Figure 18 : Twist Bioscience: Revenue Shares, by Business Unit, FY 2023
Figure 19 : Twist Bioscience: Revenue Shares, by Country/Region, FY 2023

List of Tables


Summary Table : Global Market for Gene Synthesis, by Services, Through 2028
Table 1 : Patents Related to Gene Synthesis Market, by Owner, January 2023-March 2024
Table 2 : Patents Related to Gene Synthesis Market, by Applicant, January 2023-March 2024
Table 3 : Global Market for Gene Synthesis, Through 2028
Table 4 : Global Market for Gene Synthesis, by Method, Through 2028
Table 5 : Global Market for Solid-phase Synthesis, by Region, Through 2028
Table 6 : Global Market for PCR-based Enzyme Synthesis, by Region, Through 2028
Table 7 : Global Market for Chip-based Synthesis, by Region, Through 2028
Table 8 : Global Market for Gene Synthesis, by Services, Through 2028
Table 9 : Global Market for Antibody DNA Synthesis, by Region, Through 2028
Table 10 : Global Market for Viral DNA Synthesis, by Region, Through 2028
Table 11 : Global Market for Other Synthesis Services, by Region, Through 2028
Table 12 : Global Market for Gene Synthesis, by Application, Through 2028
Table 13 : Global Market for Gene and Cell Therapy Development Applications, by Region, Through 2028
Table 14 : Global Market for Vaccine Development Applications, by Region, Through 2028
Table 15 : Global Market for Disease Diagnosis Applications, by Region, Through 2028
Table 16 : Global Market for Other Applications, by Region, Through 2028
Table 17 : Global Market for Gene Synthesis, by End User, Through 2028
Table 18 : Global Market for Gene Synthesis Used by Academic and Government Research Institutes, by Region, Through 2028
Table 19 : Global Market for Gene Synthesis Used by Biotechnology and Pharmaceutical Companies, by Region, Through 2028
Table 20 : Global Market for Gene Synthesis Used by Contract Research Organizations, by Region, Through 2028
Table 21 : Ranking of Gene Synthesis Companies, 2022
Table 22 : Mergers and Acquisitions (M&A), 2021-2023
Table 23 : Venture Funding, 2022 and 2023
Table 24 : Report Sources
Table 25 : Abbreviations Used in the Report
Table 26 : Azenta US Inc.: Company Snapshot
Table 27 : Azenta US Inc.: Financial Performance, FY 2022 and 2023
Table 28 : Azenta US Inc.: Product Portfolio
Table 29 : Azenta US Inc.: News/Key Developments, 2021-2023
Table 30 : Danaher Corp.: Company Snapshot
Table 31 : Danaher Corp.: Financial Performance, FY 2022 and 2023
Table 32 : Danaher Corp.: Product Portfolio
Table 33 : Danaher Corp.: News/Key Developments, 2023
Table 34 : Eurofins Scientific: Company Snapshot
Table 35 : Eurofins Scientific: Financial Performance, FY 2022 and 2023
Table 36 : Eurofins Scientific: Product Portfolio
Table 37 : GenScript: Company Snapshot
Table 38 : GenScript: Financial Performance, FY 2021 and 2022
Table 39 : GenScript: Product Portfolio
Table 40 : GenScript: News/Key Developments, 2023
Table 41 : Merck KgaA: Company Snapshot
Table 42 : Merck KgaA: Financial Performance, FY 2022 and 2023
Table 43 : Merck KgaA: Product Portfolio
Table 44 : Merck KgaA: News/Key Developments, 2022
Table 45 : OriGene Technologies Inc.: Company Snapshot
Table 46 : OriGene Technologies Inc.: Product Portfolio
Table 47 : OriGene Technologies Inc.: News/Key Developments, 2022
Table 48 : ProMab: Company Snapshot
Table 49 : ProMab: Product Portfolio
Table 50 : ProteoGenix: Company Snapshot
Table 51 : ProteoGenix: Product Portfolio
Table 52 : Thermo Fisher Scientific Inc.: Company Snapshot
Table 53 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023
Table 54 : Thermo Fisher Scientific Inc.: Product Portfolio
Table 55 : Twist Bioscience: Company Snapshot
Table 56 : Twist Bioscience: Financial Performance, FY 2022 and 2023
Table 57 : Twist Bioscience: Product Portfolio